---
title: "Maprotiline - Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db00934-mesh-d003866-1.html
toc: false 
---


Path ID: `DB00934_MESH_D003866_1`
{% include image.html url="images/db00934-mesh-d003866-1.png" file="db00934-mesh-d003866-1.png" alt="db00934-mesh-d003866-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C033781 | maprotiline | Drug |
| UniProt:P23975 | Sodium-dependent noradrenaline transporter | Protein |
| GO:0051620 | norepinephrine reuptake | BiologicalProcess |
| UBERON:0027221 | adrenergic system | GrossAnatomicalStructure |
| HP:0000716 | depression | PhenotypicFeature |
| MESH:D003866 | Depressive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Maprotiline | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Sodium-Dependent Noradrenaline Transporter | PARTICIPATES IN | Norepinephrine Reuptake |
| Norepinephrine Reuptake | LOCATED IN | Adrenergic System |
| Adrenergic System | PARTICIPATES IN | Depression |
| Depression | CORRELATED WITH | Depressive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00934#BE0000486](https://go.drugbank.com/drugs/DB00934#BE0000486)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/072285s021lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/072285s021lbl.pdf)
